IP Library › Patent Application 13895399
Patent Application
App. No. 13/895,399

USP2A PEPTIDES AND ANTIBODIES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/895,399
Abstract

The invention relates to novel USP2a peptides and antibodies, as well as nucleic acids related to them. The peptides, antibodies and the nucleic acids are useful for the detection, staging and monitoring of the progression of cancer, as well as for determining or monitoring the efficacy of treatment.

Claims (6)

1 . A nucleic acid molecule encoding a protein or peptide molecule selected from the group consisting of SEQ ID NO, 1, SEQ ID NO. 2, and variants thereof.

2 . The nucleic acid molecule of claim 1 , comprising at least about 5 nucleic acid bases to about 80 nucleic acid bases.

3 . The nucleic acid molecule of claim 2 , further comprising at least about 10 nucleic acid bases to about 30 nucleic acid bases.

4 . The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule is a deoxyribonucleic acid (DNA) molecule.

5 . The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule is a ribonucleic acid (RNA) molecule.

6 . The nucleic acid molecule of claims 1 , wherein the nucleic acid molecule further comprises a detectable label.

Assignments (2)
COURT ORDER Recorded Jun 1, 2017
From: NUCLEA BIOTECHNOLOGIES, INC.
To: NMDX, LLC
Reel/Frame 042562/0957 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2013
From: MURACA, PATRICK J
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 030615/0893 →